Pharmeasy Unlisted Shares
Pharmeasy Unlisted Shares Share Price
Industry retailSector pharmaDepository NSDL, CDSL
52W High
₹5,167.00
52W Low
₹5.16
1Y Return
-14.6%
Overview
About The Company
Deep Dive
Pharmeasy Unlisted Shares Unlisted Shares
Financials · IPO timeline · Growth projects
API Holdings Limited (Pharmeasy), as per its annual filings, is engaged in the business of undertaking and/or arranging or syndicating all types of business relating to the financing of industry or corporates like logistic and IT sectors. Further, during the year under review, the company had transferred its businesses of wholesale and distribution of drugs (including pharmaceutical products, medical devices, and OTC drugs) and ownership of technology and intellectual property for developing e-commerce platforms including marketplaces for facilitating the sale of pharmaceutical, medical devices, and OTC drugs to its wholly-owned subsidiaries through a slump sale on a going concern basis.
Strong
Market Position
Consistent
YoY Growth
Experienced
Management
Fundamentals
Key Indicators
A snapshot of Pharmeasy Unlisted Shares's financial health, valuation multiples and capital efficiency at a glance.
Current Share Price₹5.16
Face Value / Share₹1.00
Book Value / Share₹5.00
Price to Earning (PE)-4.90
Price / Sales1.50
Price / Book1.00
Outstanding Shares1,703.25Cr
Market Cap₹8,817.00Cr
Debt / Equity1.13
Dividend / Share₹0.00
Dividend %0.00%
Return on Total Assets-23%
Return on Equity-48%
Working Capital Return-11%
Pharmeasy Unlisted SharesNSDL, CDSL Unlisted Shares
₹5.16
Estimated total₹51.60
Settled in T+2 days · KYC verified dealers
Performance
Pricing Trends
6-Month Movement
₹5.16↗ +0.00 (+0.00%)
Financials
Financial Performance
| Indicators | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | 5,980.0 | 5,758.9 | 6,699.7 | 5,781.0 | 2,360.7 | 737.4 |
| Expense | 6,533.5 | 6,311.0 | 8,065.1 | 8,074.5 | 2,904.6 | 1,053.7 |
| EBITDA | -553.4 | -552.1 | -1,365.4 | -2,345.7 | -543.9 | -316.3 |
| Other Cost | 963.4 | 1,969.8 | 3,831.2 | -843.8 | 76.3 | 30.7 |
| PBT | -1,516.9 | -2,521.9 | -5,196.6 | -3,971.4 | -620.3 | -347.0 |
| Tax Expense | 55.5 | 11.5 | 15.2 | 21.7 | 21.1 | -11.7 |
| PAT | -1,572.4 | -2,533.4 | -5,211.8 | -3,993.2 | -641.3 | -335.3 |
| Other Inc./Exp. | 0.0 | 2.3 | 9.2 | -34.5 | 5.1 | 0.1 |
| Net Income | -1,572.4 | -2,531.1 | -5,202.6 | -4,027.7 | -636.3 | -335.2 |
| Shares O/S | 1,703.30 | 624.00 | 614.20 | 553.10 | 238.70 | 238.70 |
| EPS (₹) | -1.05 | -4.10 | -8.50 | -7.30 | -2.70 | -1.50 |
| Rev. Growth % | 3.8% | -14.0% | 15.9% | 144.9% | 220.1% | — |
| EBITDA Mgn % | -9.3% | -9.6% | -20.4% | -40.6% | -23.0% | -42.9% |
| Net Mgn % | -26.3% | -44.0% | -77.7% | -69.7% | -27.0% | -45.5% |
| EPS Growth | -74.4% | -51.8% | 16.4% | 170.4% | 80.0% | — |
Corporate
Registered Address
#
ISIN
INE0DJ201029
§
PAN
AASCA1201E
Address
902, 9th Floor, Raheja Plaza 1, B-Wing,Opposite R-City Mall, L.B.S Marg, Ghatkopar,Mumbai,400086
RTA
link intime
Leadership
Management Team
SS
Siddharth Shah
CEO & Managing Director
YB
Yatharth Bhargova
Chief Financial Officer
DS
Drashti Shah
Company Secretary
Reports
Download Financial Results
📄Annual Report 2023
▼📅Select Year
▼Press
In The News
ENTRACKR↗
PharmEasy reports Rs 5,872 Cr revenue in FY25; burn remains flat
Sep 7, 2025Learn more →
MC↗
PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits; Rahul Guha takes over
Sep 2, 2025Learn more →
Mint↗
Aamir Khan is PharmEasy's brand ambassador
Jul 29, 2025Learn more →
BUSINESS-STANDARD↗
Pharmeasy FY23 losses widen 31%, revenue increases 16% to Rs 6,644 cr
Jul 29, 2025Learn more →
ENTREPRENEUR↗
How Pharmeasy Founders Changed the Face of Pharmacy
Jul 29, 2025Learn more →
ET↗
PharmEasy logs first ebitda profit of Rs 14 crore in April, restarts funding talks
Jul 29, 2025Learn more →
YOURSTORY↗
CCI clears Ranjan Pai's proposal to acquire stake in PharmEasy
Jul 29, 2025Learn more →
MC↗
PharmEasy wins CNBC-TV18’s IBLA Young Turk of the Year Award
Jul 29, 2025Learn more →
Latest Article
From The Experts
blog↗
Api Holdings (Pharmeasy) Profitability Turnaround Story
May 30, 2026Read more →
blog↗
API Holdings 9MFY26 Financial Analysis, The Actual Story
Apr 24, 2026Read more →
Healthtech↗
How is PharmEasy doing? Know The Revival Plans
Jan 6, 2026Read more →
blog↗
Pharmeasy Planning For IPO Again After 2 Years. Is It Final?
Jan 23, 2025Read more →
blog↗
PharmEasy Sees A 92% Cut In Valuation At $458 Million
Sep 26, 2024Read more →
blog↗
Gaurav Verma Elevated To Chief Business Officer At PharmEasy
Sep 26, 2024Read more →
blog↗
PharmEasy-Owned Thyrocare To Acquire Diagnostic Business Of Polo Labs
Aug 2, 2024Read more →
blog↗
Who Is The Owner Of PharmEasy?
Jul 3, 2024Read more →
Top Unlisted companies
Current Price: ₹ 2043.93/-
Current Price: ₹ 2756.25/-
Current Price: ₹ 535.5/-
Current Price: ₹ 443.93/-
Current Price: ₹ 8741.25/-
Current Price: ₹ 260/-
Current Price: ₹ 2599.8/-
Current Price: ₹ 2600/-
Help
Frequently Asked Questions
?
Still have questions?
Our expert team typically responds within 30 minutes during market hours.
Due to past performance and potential to grow, investment in API Holdings Ltd(PharmEasy) unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of API Holdings Ltd(PharmEasy). You just need to connect with our expert share brokers, and they will help you throughout the process.
